OAM
NVLN

Oxford Asset Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Oxford Asset Management’s Portfolio NVLN Stock Details NVLN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
2017
Q4 		$138K Buy
2017
Q3 		$201K Sell
2017
Q2 		$472K Sell
2017
Q1 		$1.24M Buy